Healthy Living/WellnessSarepta again seeks FDA approval for drug treating Duchenne muscular dystrophy Sarepta will file a new application for eteplirsen with the FDA. The eteplirsen drug will treat Duchenne muscular dystrophy, which affects young boys.by Anu Passary
Healthy Living/WellnessFDA cracks down on e-cigarette industry through new proposed regulationsby Vamien McKalin
Healthy Living/WellnessBeer price hike: New FDA rule to cost millions and raise beer pricesby Anne Francis
Healthy Living/WellnessUse of laparoscopic power morcellation for hysterectomy or fibroid removal may spread cancer: FDAby Anu Passary
Healthy Living/WellnessFDA approval of Tanzeum drug is good news for type 2 diabetes patientsby Jim Algar
Healthy Living/WellnessE-cigarettes attract youngsters using music festivals, tactics banned for traditional tobacco productsby Rhodi Lee
Healthy Living/WellnessPure honey vs. honey blend, FDA fights misbranding to protect consumersby Rhodi Lee
Healthy Living/WellnessFDA approves life-saving Evzio auto-injector for painkiller overdoseby Rhodi Lee
Healthy Living/WellnessCDC reports a sharp spike in e-cigarette poisonings over the past three yearsby Tabitha Laffernis
Healthy Living/WellnessFDA approves hay fever drug Oralair: Goodbye sneezing and allergy shots.by Rhodi Lee
Healthy Living/WellnessFDA advisers give thumbs up to MannKind's inhaled insulin drug for diabeticsby Maryanne Moll
Apple to Release iOS 18.2 Earlier This December, Featuring Siri's ChatGPT, Apple Intelligence Upgrades